Paul Tudor Jones's TSHA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 143,575 shares of Taysha Gene Therapies, Inc. (TSHA) worth $641,780, representing 0.00% of the portfolio. First purchased in 2020-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in TSHA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 143,575 shares. Largest reduction occurred in Q3 2024, reducing 26,634 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Taysha Gene Therapies (TSHA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Taysha Gene Therapies (TSHA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +143,575 | New Buy | 143,575 | $4.47 |
| Q3 2024 | -26,634 | Sold Out | 0 | $0.00 |
| Q2 2024 | +26,634 | New Buy | 26,634 | $2.24 |
| Q4 2020 | -9,725 | Sold Out | 0 | $0.00 |
| Q3 2020 | +9,725 | New Buy | 9,725 | $22.42 |
Paul Tudor Jones's Taysha Gene Therapies Investment FAQs
Paul Tudor Jones first purchased Taysha Gene Therapies, Inc. (TSHA) in Q3 2020, acquiring 9,725 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Taysha Gene Therapies, Inc. (TSHA) for 5 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Taysha Gene Therapies, Inc. (TSHA) was in Q1 2026, adding 143,575 shares worth $641,780.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 143,575 shares of Taysha Gene Therapies, Inc. (TSHA), valued at approximately $641,780.
As of the Q1 2026 filing, Taysha Gene Therapies, Inc. (TSHA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Taysha Gene Therapies, Inc. (TSHA) was 143,575 shares, as reported at the end of Q1 2026.